Neutrophil movement may shift damage between organs and mimic lasting recovery
Suppressing prostaglandin E2 receptor subtype 2 (EP2) while blocking neutrophil engulfment may shift damage between organs, making early muscle improvement look like lasting recovery. Improvement across muscle, heart and lungs for months without transfer of the cell burden would refute this hypothesis.
Stage of verification
- Hypothesis published2026-09-30
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Ageing mechanism
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

Receptor or channel
EP2 receptor
A receptor whose activity can be suppressed
Where this hypothesis actsDuring blockade of neutrophil engulfment, with prolonged assessment of muscle, lung and heart function
Hypotheses on this target 5
Lower level
Higher level
Blockade5
Agonism
Desensitisation
Function restoration
Function preservation

What is proposed
Blockade
Suppress EP2 activity
With whatNot stated in the record
HowNot stated in the record
Possible result
Possible local functional improvement with redistribution of neutrophils and delayed damage in other organs
From the recordПодавление EP2 может действительно улучшать отдельные функции

Immune response
Efferocytosis
The engulfment and clearance of apoptotic cells by phagocytes
Where this hypothesis actsDuring EP2 suppression, while tracking neutrophils from their tissue of origin into blood and distant organs
Hypotheses on this target 8
Inhibition5
Activation2
Function preservation
Clearance restoration1
Immunosuppression
Feedback restoration
Rhythm restoration

What is proposed
Inhibition
Block neutrophil engulfment
With whatNot stated in the record
HowNot stated in the record
Possible result
Expected persistence and redistribution of neutrophils without sustained functional benefit across three systems
From the recordПосле подавления EP2 на фоне блокады поглощения меченые нейтрофилы исчезают из исходной ткани, но сохраняются в крови и обнаруживаются в удалённых органах.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
An early improvement in one organ can conceal damage appearing later somewhere else. The unexpected proposal is that suppressing EP2 while preventing other cells from swallowing neutrophils could allow active neutrophils to leave the improving tissue and carry damage elsewhere. This is a hypothesis generated by the pipeline, not a measured explanation of recovery.
- EP2 suppression is proposed to improve some local functions while neutrophil swallowing remains blocked.
- Active neutrophils are proposed to leave the original tissue instead of being swallowed and digested there.
- Departing neutrophils are proposed to remain in blood and reach distant organs, redistributing damage rather than eliminating it.
- Early muscle improvement is proposed to precede lung or heart deterioration after repeated ordinary exertion.
- Separate measurements over an extended period are predicted to reveal no sustained, coordinated functional benefit across muscle, lungs and heart.
A room can look cleaner because its rubbish has been carried into other rooms. Inspecting only the first room, or inspecting the others before the rubbish arrives, mistakes relocation for cleanup.
Where the picture breaks: Neutrophils are active cells whose effects can change, not inert rubbish. The analogy cannot establish that departing cells damage their destination; the rival explanations also allow retained neutrophils or their products to support protection.
- Master questionstep 01 of 04
Aging processes may reinforce one another, so changing a shared cause might benefit several body systems at once.
Rests on: The goal is to find a single intervention with benefits across several systems rather than benefits confined to one.
AssumptionThe search assumes that an accessible shared cause could produce benefits across several systems. The supplied material does not establish that such a target exists.
- Goal pillarstep 02 of 04
Recovery should resist becoming locked into a damaged state.
Rests on: The master question identifies mutually reinforcing aging processes as a possible reason damage persists and a shared intervention might help.
Stated in the chain - Gap questionstep 03 of 04
Lasting benefits across several systems might survive EP2 suppression even when the recovery of neutrophil removal is selectively prevented. Such persistence would challenge the claim that removal is the shared cause of improvement.
Rests on: The preceding stage calls for durable recovery, but does not connect that goal to EP2 or explain why restored neutrophil removal is the candidate shared cause.
LeapThe supplied chain does not provide the bridge from resistance to persistent damage to EP2 suppression and restored removal of neutrophils. The screened sources do not establish that removing whole neutrophils causes lasting benefit across several systems.
- Hypothesisstep 04 of 04
Apparent lasting recovery could instead combine genuine early muscle improvement with delayed lung or heart damage caused by departing neutrophils. The proposal predicts that separate, extended measurements would reveal no sustained, coordinated improvement across all three systems.S5
Rests on: The gap question supplies the setting: EP2 suppression while neutrophil swallowing is blocked. S5, a mouse study in Cell Death & Disease from 2024, reports evidence suggesting that a circulating signal draws neutrophils away from inflammatory sites and might spread inflammation; it does not test EP2 suppression or establish transfer between organs, delayed functional damage, or apparent lasting recovery.
Supported by literature
What is carried, and what is not. Of the five proposed links listed here, one has direct background support in the supplied source excerpts: departure from an inflammatory site. S5 suggests such departure and possible spread of inflammation in mice, but neither it nor the other supplied excerpts establishes the full sequence from EP2 suppression to cell redistribution, delayed organ damage and absence of lasting benefit.S5
Where the reasoning is carried by something unstated · 2
- Master question. The search assumes that an accessible shared cause could produce benefits across several systems. The supplied material does not establish that such a target exists.
- Gap question. The supplied chain does not provide the bridge from resistance to persistent damage to EP2 suppression and restored removal of neutrophils. The screened sources do not establish that removing whole neutrophils causes lasting benefit across several systems. Establish the missing link before relying on this step.
How a result here could mislead · 3
- A tracking label in a distant organ could be counted as an intact migrated neutrophil when it is actually inside a macrophage, an immune cell that swallows cells and material. What closes it: The proposed tracking must distinguish intact labeled neutrophils from label transferred to macrophages, and establish that the tracked cells originated in the specified tissue.
- Early muscle improvement or an average inflammation measurement could be treated as recovery across the body while delayed lung or heart deterioration remains hidden. What closes it: Muscle, lung and heart function must be measured separately and repeatedly, including after the specified repeated ordinary exertion. The observation period and criteria for coordinated benefit must be fixed before results are examined; the supplied material gives no exact duration or numerical criteria.
- Finding migrated neutrophils alongside distant deterioration could be read as proof that the cells caused the damage. The proposed tracking establishes location and timing, but does not itself separate cell-mediated damage from another effect of treatment or blocked swallowing. What closes it: Attribution of damage to redistribution requires a comparison that separates the effect of cell movement from the effects of EP2 suppression and blocked swallowing. Such a comparison is not specified in the supplied test.
What would make this wrong. Confirmed improvement of muscle, lung and heart function sustained for months during EP2 suppression and verified blockade of neutrophil swallowing, with no transfer of the neutrophil burden to distant organs, would contradict the hypothesis's defining prediction. The supplied material specifies neither an exact number of months nor numerical thresholds for improvement or absence of transfer.
What it would change. If the hypothesis held, apparent benefit in several measurements would not be enough to identify a shared cause worth targeting for life extension: the work would have to establish that damage had been reduced across organs and over time. Persistence of an early benefit despite blocked neutrophil swallowing would also fail, by itself, to disprove a causal role for removal. Even then, the supplied proposal would not establish longer life, benefits in humans, or a general explanation of aging; it does not specify the species for its proposed test.
Sources read · 7
PGE2 inhibits neutrophil phagocytosis through the EP2R-cAMP-PTEN pathway. · Immunity, inflammation and disease · 2022
“The EP2 receptor antagonist AH‐6089 partially blocked the inhibition of neutrophil phagocytosis PGE2.”
Does not settle: Источник не оценивает миграцию нейтрофилов между органами, повреждение лёгких или сердца, длительные функциональные исходы, многосистемную пользу или показатель SPV_11.
E-prostanoid 2 receptor signaling suppresses lung innate immunity against Streptococcus pneumoniae. · Prostaglandins & other lipid mediators · 2012
“Bacterial clearance and survival were significantly improved in vivo in EP2 −/− mice and it correlated with greater neutrophilic inflammation and higher lung IL-12 levels.”
Does not settle: Источник описывает мышиную модель пневмококковой пневмонии и не устанавливает длительные многосистемные последствия подавления EP2, перемещение активных нейтрофилов между органами, повреждение лёгких или сердца, функцию мышц либо изменение SPV_11.
KRIT1-mediated regulation of neutrophil adhesion and motility. · The FEBS journal · 2023
“Altogether, we show that KRIT1 regulates neutrophil adhesion and migration, likely through regulation of integrin activation, which can lead to altered inflammatory responses in vivo.”
Does not settle: Источник не изучает подавление EP2, повреждение сердца или мышц, перенос повреждения между органами, длительные функциональные исходы либо SPV_11.
Chemerin attracts neutrophil reverse migration by interacting with C-C motif chemokine receptor-like 2. · Cell death & disease · 2024
“These results suggest that circulating chemerin attracts neutrophils to leave inflammatory sites by interacting with CCRL2, which might involve in the dissemination of inflammation.”
Does not settle: This mouse study does not test EP2 inhibition, muscle, heart, or long-term multisystem functional decline; it does not establish that redistribution occurs between organs or that it mimics lasting recovery.
Endogenous Ceramide 24:1 Constrains Th17-Driven Neutrophilic Inflammation by Antagonizing EP2 Signaling. · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
“Mechanistically, Cer24:1 antagonizes the EP2–JAK2–STAT3 axis, thereby attenuating EP2‐driven STAT3 activation and restraining the Th17–neutrophil program.”
Does not settle: Источник не исследует блокаду поглощения нейтрофилов, перемещение нейтрофилов между органами, повреждение лёгких или сердца, длительную многосистемную пользу либо скорость функционального ухудшения SPV_11.
Migration of neutrophils from blood to tissue: alteration of modulatory effects of prostanoid on superoxide generation in rabbits and humans. · Life sciences · 1997
“Furthermore, it can be concluded that neutrophils become less responsive to prostanoids in terms of fMLP-stimulated superoxide production in association with their migration from blood to tissue.”
Does not settle: Источник не изучает подавление EP2, перераспределение нейтрофилов между органами, повреждение лёгких или сердца, длительные функциональные исходы либо SPV_11.
Intrauterine group A streptococcal infections are exacerbated by prostaglandin E2. · Journal of immunology (Baltimore, Md. : 1950) · 2013
“We observed that while GAS infection alone or PGE 2 injection alone did not significantly alter neutrophil populations, a significant increase in tissue neutrophils was observed when infected mice were treated with PGE 2 ( ).”
Does not settle: Источник описывает острое заражение матки стрептококком группы A у мышей и действие PGE2. Он не исследует подавление EP2, поглощение или выход нейтрофилов, перенос повреждения между органами, функции мышц, лёгких или сердца, а также длительную многосистемную динамику SPV_11.
The gap this hypothesis explains
Two live hypotheses pull in opposite directions here, and the field has not chosen between them.
Does suppressing a cell signal still benefit several body systems when improved removal of worn-out immune cells is blocked?
Original wording · exactly as the pipeline generated it
Сохранится ли многосистемная польза подавления EP2, если избирательно воспрепятствовать восстановлению удаления нейтрофилов, и опровергнет ли такой результат очистку как общее причинное звено?
What this question is asking
The question asks whether improved removal of worn-out neutrophils, a type of immune cell, is necessary for benefits across several body systems. The intervention suppresses signaling through E prostanoid receptor subtype 2 (EP2) in tissue-resident macrophages, immune cells that live in tissues and remove cellular material. The comparison is between suppression that allows neutrophil removal to improve and the same suppression with that improvement selectively prevented. The question assumes that suppression improves both removal and several aspects of health in aged mice, while treating removal as a possible shared cause of those benefits. It also asks whether benefits persisting when improved removal is blocked would disprove that proposed causal explanation.
- E prostanoid receptor subtype 2 (EP2)
- A cell receptor through which prostaglandin E2 sends signals. The question concerns reducing its signaling in tissue-resident macrophages; the supplied sources report different consequences of this signaling in different settings.
- Prostaglandin E2
- A signaling molecule that acts through receptors including EP2. In the supplied sources, its signaling is linked to increased removal of dying cells, impaired bacterial killing, and protection against scarring, so its effects cannot be reduced to a single beneficial or harmful role.
- Neutrophils
- A type of immune cell. The question concerns removal of worn-out neutrophils, rather than their production or every function they perform.
- Senescent neutrophils
- The aged or worn-out neutrophils named in S1's title. The supplied material does not specify how that state was identified or whether it matches the dying-cell states studied in the other sources.
- Tissue-resident macrophages
- Immune cells that reside in tissues and can ingest cells and other material. They are the cells whose EP2 signaling was reduced in S1.
- Clearance
- Removal of cells or other material from a tissue. Here, the proposed causal step is improved removal of neutrophils; reduced accumulation alone would not specify how that reduction occurred.
- Programmed cell death
- An organized process through which cells die. The dying cells ingested in S6 should not automatically be treated as equivalent to every neutrophil described as senescent in S1.
- Mitochondrial fitness
- The functional condition of mitochondria, structures within cells involved in supplying usable energy. S1 reports preservation of this condition but the supplied quotation does not specify its measurement.
- Inflammation
- A tissue and immune response to injury or threats. Body-wide inflammation is one of S1's reported outcomes, while the question asks whether improved cell removal explains its reduction.
- Cognitive decline and frailty
- Cognitive decline means worsening abilities such as memory and thinking; frailty means increased vulnerability associated with reduced physical reserves. Both are outcomes named in S1, but their measurement criteria are not supplied.
- Hydrogen peroxide
- A reactive chemical involved in the bacterial-killing mechanism described in S5. That source links reduced production of it to impaired bacterial killing.
- Scarring
- Formation of fibrous tissue, also called fibrosis. S8 concerns a possible loss of protection against this process in the uterine lining.
- Selective prevention
- The question's assumed ability to stop improvement in neutrophil removal while keeping EP2 suppression effective and avoiding other changes that could explain the outcomes. The supplied sources do not establish that this separation was achieved.
- Necessary and sufficient causes
- A necessary step must occur for a particular benefit to occur under the stated conditions. A sufficient step can produce that benefit on its own; showing necessity does not establish sufficiency.
Suppressing EP2 improves neutrophil clearance and macrophage condition in aged mice and produces benefits across several body systems, with clearance proposed as their common causal link.
Neutrophils are immune cells, and tissue-resident macrophages are cells that can remove them as they become worn out. The assumption is that reducing signaling through a receptor on these macrophages improves their condition and removal work, alongside benefits elsewhere in the body. If established, that connection would provide the starting point for asking whether improved removal is required for those benefits.
S1 directly reports that reducing macrophage EP2 signaling in aged mice preserved mitochondrial fitness and prevented several adverse outcomes. Its title identifies restored clearance of senescent neutrophils as the subject, but the supplied abstract quotation does not detail that clearance result or establish its necessity for the broader benefits. S6 reports increased uptake of dying cells following EP2 activation in another setting, so a general claim that less EP2 signaling necessarily improves clearance is not supported. None of the supplied passages establishes clearance as the necessary common cause.S1S6
The same question asked without the part nothing read establishes:
- In aged mice, do the benefits of reducing EP2 signaling persist when improved neutrophil removal is selectively prevented?
- Which benefits of reducing EP2 signaling in aged mice require improved neutrophil removal?
- Benefits persist across systems If improved neutrophil removal were genuinely prevented while receptor suppression remained effective, persistent benefits would mean that this improvement was not necessary for those measured benefits under those conditions. That would challenge clearance restoration as their required common cause, while leaving possible contributions from existing clearance or other settings unresolved.
- Benefits disappear across systems Under the question's assumption of selective interference, losing the benefits would support a requirement for improved neutrophil removal. It would not by itself establish that removal is the sole cause or that improving removal alone is sufficient to produce those benefits.
- Some benefits persist and others disappear Under the same selectivity assumption, the outcomes would differ in their dependence on improved neutrophil removal. Clearance restoration could then explain some benefits without serving as a necessary common link for every measured system.
The proposed chain runs from reduced receptor signaling to improved removal of worn-out immune cells, then to less inflammation and better function across several body systems. If improved removal is necessary, blocking that improvement would interrupt the chain despite continued receptor suppression. If benefits persist, the proposed explanation would need to distinguish benefits that require improved removal from benefits that do not. Mistaking an accompanying change for a necessary cause would misidentify why the intervention works; assuming that receptor suppression always helps would also overlook the opposing effects reported in other biological settings.
Подавление EP2 улучшает очистку и состояние макрофагов у мышей, RL-1; необходимость очистки для общего устойчивого эффекта отдельно не установлена.
Воспаление и функции возвращаются в заданные диапазоны за дни или недели; повторные нагрузки сохраняют восстановление нескольких систем месяцами.
Требуется разорвать предполагаемую причинную цепь и проверить, исчезает ли многосистемная польза при сохранённом воздействии на EP2.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Предполагаемая устойчивая многосистемная польза при блокаде поглощения нейтрофилов отсутствует как общий результат. Подавление EP2 может действительно улучшать отдельные функции, одновременно способствуя выходу активных нейтрофилов из исследуемой ткани и переносу повреждения в другой орган. Ранние измерения мышцы и усреднённые показатели воспаления объединяют местное улучшение с ещё не проявившимся ухудшением лёгких или сердца. Таким образом, причинная ошибка состоит в признании перераспределения повреждения общим восстановлением. Стабилизация скорости функционального ухудшения SPV_11 при раздельной длительной оценке систем должна отсутствовать.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
После подавления EP2 на фоне блокады поглощения меченые нейтрофилы исчезают из исходной ткани, но сохраняются в крови и обнаруживаются в удалённых органах. Раннее улучшение мышцы сопровождается отсроченным ухудшением лёгочной или сердечной функции после повторной обычной нагрузки. За заранее заданный период наблюдения согласованного функционального выигрыша трёх систем нет. Подтверждённое улучшение всех трёх систем на протяжении месяцев при отсутствии переноса клеточной нагрузки опровергает эту гипотезу.
Would tell it apart from at least one rival. The prediction specifies observable cell redistribution, sequential functional changes, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Отслеживание клеток из конкретного очага и серийные функциональные измерения позволяют отличить переваривание нейтрофилов от их перемещения. Перенос метки в макрофаги необходимо отделять от присутствия целых меченых нейтрофилов. Биопсии и терминальные исследования распределяют между сопоставимыми группами.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
После подавления EP2 на фоне блокады поглощения меченые нейтрофилы исчезают из исходной ткани, но сохраняются в крови и обнаруживаются в удалённых органах. Раннее улучшение мышцы сопровождается отсроченным ухудшением лёгочной или сердечной функции после повторной обычной нагрузки. За заранее заданный период наблюдения согласованного функционального выигрыша трёх систем нет. Подтверждённое улучшение всех трёх систем на протяжении месяцев при отсутствии переноса клеточной нагрузки опровергает эту гипотезу.
- What would separate them
Delaying neutrophil uptake may preserve vesicle-mediated complement inhibition predicts: При подтверждённом подавлении EP2 и одинаковом исходном повреждении блокада поглощения нейтрофилов дополнительно улучшает восстановление мышцы, сердца и лёгких. Этот дополнительный выигрыш исчезает при нейтрофил-специфическом выключении CD55 и возвращается после введения очищенных CD55-положительных везикул. Напротив, независимое ускорение удаления нейтрофилов при сохранённой блокаде EP2 ухудшает восстановление, если происходит до образования защитных везикул. Простое сохранение пользы при блокаде поглощения для подтверждения этой гипотезы недостаточно.
- What would separate them
Vesicle removal may limit damage from elastase shielded against its natural inhibitor predicts: При блокаде поглощения целых нейтрофилов эффект подавления EP2 сохраняется только при снижении количества везикул с активной эластазой. Возврат очищенной фракции таких везикул устраняет пользу; равное количество везикул с инактивированной эластазой этого не делает. При одинаковой активности против свободной эластазы малый ингибитор подавляет везикулярную протеазу и восстанавливает функции эффективнее крупного ингибитора. После отделения эластазы от поверхности размерная зависимость исчезает.
- What would separate them
Suppressing a prostaglandin receptor may curb ferroptosis through itaconate predicts: При подавлении EP2 и блокаде поглощения нейтрофилов функции улучшаются на фоне сопоставимых количества нейтрофилов, активности комплемента и внеклеточной эластазы. Одновременно снижаются окисленные фосфолипиды и гибель паренхиматозных клеток. Макрофаг-специфическое выключение фермента синтеза итаконата ACOD1 устраняет этот выигрыш; прямое подавление ферроптоза в клетках-мишенях восстанавливает его при продолжающейся блокаде поглощения. Отсутствие увеличения потока природного итаконата после подавления EP2 опровергает предложенную связь.
- What would separate them
Shared lipid synthesis in neutrophils and platelets may limit tissue damage predicts: Польза подавления EP2 сохраняется при блокаде поглощения нейтрофилов и сопровождается усилением образования липоксинов из изотопно меченного нейтрофильного предшественника. Тромбоцит-специфическое выключение 12-липоксигеназы устраняет этот эффект при сохранённых количестве нейтрофилов, активности CD55 на везикулах и потоке итаконата. Введение соответствующего продукта синтеза восстанавливает функции. Отсутствие зависимости от тромбоцитарного фермента при подтверждённом его выключении опровергает гипотезу.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.